Results 131 to 140 of about 657,091 (294)
, 1967 Reporter receives student financing (p. 1); RAISA elects officers; Baker named president (p. 1); Conflicts discussed at meeting (p. 1); Frosh Daze ’67 committee set (p. 1); Workers walkout at new campus site (p. 1); Dorm council unsuccessful (p.
RIT Reporter Staff
core
FEBS Letters, EarlyView.The process of internalization of the Shiga toxin A subunit via formation of a complex with the Shiga toxin B subunit, which specifically binds to the Gb3 receptor. The peptide is designed to act as a carrier of drugs into cancer cells. Here, we explored the potential of peptides derived from the catalytic A subunit of Shiga toxin (STxA) to be drug ...
Giulia Opassi +6 more
wiley +1 more source
RIT Reporter - March 28th 1955
, 1955 Senior Retailers Observe Markets in New York City (p. 2); CCNY President to Speak on WUS (p. 2); Reporter Photographers Contribute Their Free Time (p. 2); Clark Lounge Gets New Furniture (p. 2); Scholarship Fund Honors Mrs. Adele Hathaway Clark (p.
RIT Reporter Staff
core
The role of miR‐335‐5p in the redifferentiation of BRAF p.V600E thyroid cancers
Molecular Oncology, EarlyView.The BRAF p.V600E mutation promotes thyroid cancer dedifferentiation and radioiodine resistance. Using a network approach, we identified miR‐335‐5p as a key regulator of BRAF‐mutated thyroid tumors. Restoring miR‐335‐5p increased thyroid‐specific gene expression and iodine uptake in cells and organoids.
Valeria Pecce +11 more
wiley +1 more source
, 1966 Gregory, Ortman, Shoulet resign from Reporter staff (p. 2); Paul Smith holds shortest term in Senate history (p. 2); Homecoming begins today with an alumni luncheon (p. 2); Althea Richardson appointed editor of 1967 Techmila (p.
RIT Reporter Staff
core
Molecular Oncology, EarlyView.Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source
, 1969 Student Senate Saves Salaries (p. 1); Greg looks back (p. 3); Reprofile (p. 2); Top Editors and Staff Members Resign form Reporter (p. 3); What’s Happening (p. 3); NTID Display to Tour (p. 3); Up, North, South Elect (p. 3); Total Environment Out (p. 3);
RIT Reporter Staff
core
Tumour–host interactions in Drosophila: mechanisms in the tumour micro‐ and macroenvironment
Molecular Oncology, EarlyView.This review examines how tumour–host crosstalk takes place at multiple levels of biological organisation, from local cell competition and immune crosstalk to organism‐wide metabolic and physiological collapse. Here, we integrate findings from Drosophila melanogaster studies that reveal conserved mechanisms through which tumours hijack host systems to ...
José Teles‐Reis, Tor Erik Rusten
wiley +1 more source
, 1966 RIT students do their part (p. 1); Students win battle on cigarette machines (p. 1); The Bitter End at Blue Midnight (p. 1); Winter concert set for Feb. 27 (p. 1); Gregory replaces Wootton as Reporter Editor-in-chief (p. 1); A final note of praise (p. 2);
RIT Reporter Staff
core
Molecular Oncology, EarlyView.In this explorative study, the abundance of circular RNA molecules in bone marrow stem cells was found to be elevated in patients with high‐risk myelodysplastic neoplasms, and to be associated with an increased risk of progression to acute myeloid leukemia.
Eileen Wedge +17 more
wiley +1 more source